Keywords: cangene, gets, orphan, status, hepagam, canada, corp

Cangene gets orphan status for HepaGam

Article | 07 April 2008

Print This

Canada's Cangene Corp says that its HepaGam B (hepatitis B immune globulin intravenous [human]), has received orphan drug exclusive approval ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in